Apyx Medical Corp - Common Stock (APYX)

CUSIP: 03837C106

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock
Shares outstanding
41,168,218
Total 13F shares
19,582,685
Share change
+472,844
Total reported value
$127,931,812
Price per share
$6.53
Number of holders
70
Value change
-$1,520,009
Number of buys
30
Number of sells
36

Security key

03837C106

Report period

Q1 2022

Institutions

70

Top holders

10

Top shareholders of APYX - Apyx Medical Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RTW INVESTMENTS, LP
13F
Company
8.3%
3,398,279
$43,566,000 31 Dec 2021
13F
Archon Capital Management LLC
13F
Company
5.3%
2,194,118
$28,129,000 31 Dec 2021
13F
BlackRock Finance, Inc.
13F
Company
4.8%
1,990,073
$25,513,000 31 Dec 2021
13F
COWEN AND COMPANY, LLC
13F
Company
4.6%
1,902,003
$24,384,000 31 Dec 2021
13F
VANGUARD GROUP INC
13F
Company
3.8%
1,575,063
$20,193,000 31 Dec 2021
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
2%
842,583
$10,802,000 31 Dec 2021
13F
HORIZON KINETICS ASSET MANAGEMENT LLC
13F
Company
1.5%
615,000
$7,884,000 31 Dec 2021
13F
STATE STREET CORP
13F
Company
1.3%
542,464
$6,954,000 31 Dec 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.3%
527,107
$6,757,000 31 Dec 2021
13F
Taylor Frigon Capital Management LLC
13F
Company
1.2%
508,580
$6,520,000 31 Dec 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.2%
497,764
$6,381,000 31 Dec 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.2%
483,795
$6,202,000 31 Dec 2021
13F
ROYCE & ASSOCIATES LP
13F
Company
1.2%
474,068
$6,078,000 31 Dec 2021
13F
Invenire Partners, LP
13F
Company
0.85%
348,007
$4,461,450 31 Dec 2021
13F
Raymond James Financial Services Advisors, Inc.
13F
Company
0.72%
296,456
$3,801,000 31 Dec 2021
13F
NORTHERN TRUST CORP
13F
Company
0.72%
294,881
$3,781,000 31 Dec 2021
13F
Cowen Prime Advisors LLC
13F
Company
0.61%
251,759
$3,228,000 31 Dec 2021
13F
Informed Momentum Co LLC
13F
Company
0.51%
208,852
$2,677,000 31 Dec 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.45%
183,667
$2,355,000 31 Dec 2021
13F
Russell Investments Group, Ltd.
13F
Company
0.38%
154,921
$1,984,000 31 Dec 2021
13F
Millrace Asset Group, Inc.
13F
Company
0.36%
148,923
$1,909,000 31 Dec 2021
13F
Calamos Advisors LLC
13F
Company
0.34%
138,699
$1,778,000 31 Dec 2021
13F
Global IMC LLC
13F
Company
0.3%
122,181
$1,566,000 31 Dec 2021
13F
ProVise Management Group, LLC
13F
Company
0.27%
111,189
$1,425,000 31 Dec 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.27%
110,719
$1,420,000 31 Dec 2021
13F
Bank of New York Mellon Corp
13F
Company
0.24%
100,048
$1,283,000 31 Dec 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.21%
85,991
$1,065,000 31 Dec 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.2%
80,775
$1,036,000 31 Dec 2021
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.18%
73,728
$945,000 31 Dec 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.16%
66,604
$853,000 31 Dec 2021
13F
GREENWOOD CAPITAL ASSOCIATES LLC
13F
Company
0.15%
62,049
$795,000 31 Dec 2021
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.13%
54,678
$701,000 31 Dec 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.13%
54,287
$696,000 31 Dec 2021
13F
FRANKLIN RESOURCES INC
13F
Company
0.13%
53,939
$691,000 31 Dec 2021
13F
WHITE PINE CAPITAL LLC
13F
Company
0.11%
45,133
$579,000 31 Dec 2021
13F
WOLFF WIESE MAGANA LLC
13F
Company
0.09%
36,519
$468,000 31 Dec 2021
13F
MORGAN STANLEY
13F
Company
0.08%
32,851
$422,000 31 Dec 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.08%
32,044
$411,000 31 Dec 2021
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.07%
27,705
$355,000 31 Dec 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.06%
23,459
$301,000 31 Dec 2021
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.05%
19,922
$255,000 31 Dec 2021
13F
DEUTSCHE BANK AG\
13F
Company
0.05%
19,684
$252,000 31 Dec 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.05%
19,416
$249,000 31 Dec 2021
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.05%
18,711
$240,000 31 Dec 2021
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
0.04%
17,738
$227,000 31 Dec 2021
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.04%
17,218
$221,000 31 Dec 2021
13F
SALEM INVESTMENT COUNSELORS INC
13F
Company
0.04%
17,010
$218,000 31 Dec 2021
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.04%
16,985
$218,000 31 Dec 2021
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.04%
16,575
$212,000 31 Dec 2021
13F
STRS OHIO
13F
Company
0.04%
16,400
$210,000 31 Dec 2021
13F

Institutional Holders of Apyx Medical Corp - Common Stock (APYX) as of Q1 2022

As of 31 Mar 2022, Apyx Medical Corp - Common Stock (APYX) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,582,685 shares. The largest 10 holders included RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, Archon Capital Management LLC, BlackRock Inc., VANGUARD GROUP INC, PURA VIDA INVESTMENTS, LLC, HORIZON KINETICS ASSET MANAGEMENT LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, and RENAISSANCE TECHNOLOGIES LLC. This page lists 70 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
74
Q1 2022 holders
70
Holder diff
-4
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 Value $ Q1 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .